224 related articles for article (PubMed ID: 17474807)
1. Assessing the onset of antidepressant-induced sexual dysfunction using interactive voice response technology.
Dunn JA; Arakawa R; Greist JH; Clayton AH
J Clin Psychiatry; 2007 Apr; 68(4):525-32. PubMed ID: 17474807
[TBL] [Abstract][Full Text] [Related]
2. Paroxetine, but not Vortioxetine, Impairs Sexual Functioning Compared With Placebo in Healthy Adults: A Randomized, Controlled Trial.
Jacobsen P; Zhong W; Nomikos G; Clayton A
J Sex Med; 2019 Oct; 16(10):1638-1649. PubMed ID: 31405765
[TBL] [Abstract][Full Text] [Related]
3. Effect of Vortioxetine vs. Escitalopram on Sexual Functioning in Adults with Well-Treated Major Depressive Disorder Experiencing SSRI-Induced Sexual Dysfunction.
Jacobsen PL; Mahableshwarkar AR; Chen Y; Chrones L; Clayton AH
J Sex Med; 2015 Oct; 12(10):2036-48. PubMed ID: 26331383
[TBL] [Abstract][Full Text] [Related]
4. Antidepressant-induced sexual dysfunction during treatment with moclobemide, paroxetine, sertraline, and venlafaxine.
Kennedy SH; Eisfeld BS; Dickens SE; Bacchiochi JR; Bagby RM
J Clin Psychiatry; 2000 Apr; 61(4):276-81. PubMed ID: 10830148
[TBL] [Abstract][Full Text] [Related]
5. Incidence of sexual side effects in refractory depression during treatment with citalopram or paroxetine.
Landén M; Högberg P; Thase ME
J Clin Psychiatry; 2005 Jan; 66(1):100-6. PubMed ID: 15669895
[TBL] [Abstract][Full Text] [Related]
6. Sexual dysfunction during treatment of major depressive disorder with vilazodone, citalopram, or placebo: results from a phase IV clinical trial.
Clayton AH; Gommoll C; Chen D; Nunez R; Mathews M
Int Clin Psychopharmacol; 2015 Jul; 30(4):216-23. PubMed ID: 26039688
[TBL] [Abstract][Full Text] [Related]
7. A placebo-controlled trial of bupropion SR as an antidote for selective serotonin reuptake inhibitor-induced sexual dysfunction.
Clayton AH; Warnock JK; Kornstein SG; Pinkerton R; Sheldon-Keller A; McGarvey EL
J Clin Psychiatry; 2004 Jan; 65(1):62-7. PubMed ID: 14744170
[TBL] [Abstract][Full Text] [Related]
8. Sexual functioning assessed in 4 double-blind placebo- and paroxetine-controlled trials of duloxetine for major depressive disorder.
Delgado PL; Brannan SK; Mallinckrodt CH; Tran PV; McNamara RK; Wang F; Watkin JG; Detke MJ
J Clin Psychiatry; 2005 Jun; 66(6):686-92. PubMed ID: 15960560
[TBL] [Abstract][Full Text] [Related]
9. A placebo-controlled comparison of the antidepressant efficacy and effects on sexual functioning of sustained-release bupropion and sertraline.
Croft H; Settle E; Houser T; Batey SR; Donahue RM; Ascher JA
Clin Ther; 1999 Apr; 21(4):643-58. PubMed ID: 10363731
[TBL] [Abstract][Full Text] [Related]
10. Summary of findings from the FDA regulatory science forum on measuring sexual dysfunction in depression trials.
Kronstein PD; Ishida E; Khin NA; Chang E; Hung HM; Temple RJ; Yang P
J Clin Psychiatry; 2015 Aug; 76(8):1050-9. PubMed ID: 26335083
[TBL] [Abstract][Full Text] [Related]
11. Bupropion extended release compared with escitalopram: effects on sexual functioning and antidepressant efficacy in 2 randomized, double-blind, placebo-controlled studies.
Clayton AH; Croft HA; Horrigan JP; Wightman DS; Krishen A; Richard NE; Modell JG
J Clin Psychiatry; 2006 May; 67(5):736-46. PubMed ID: 16841623
[TBL] [Abstract][Full Text] [Related]
12. Changes in sexual functioning associated with duloxetine, escitalopram, and placebo in the treatment of patients with major depressive disorder.
Clayton A; Kornstein S; Prakash A; Mallinckrodt C; Wohlreich M
J Sex Med; 2007 Jul; 4(4 Pt 1):917-29. PubMed ID: 17627739
[TBL] [Abstract][Full Text] [Related]
13. Sexual function during bupropion or paroxetine treatment of major depressive disorder.
Kennedy SH; Fulton KA; Bagby RM; Greene AL; Cohen NL; Rafi-Tari S
Can J Psychiatry; 2006 Mar; 51(4):234-42. PubMed ID: 16629348
[TBL] [Abstract][Full Text] [Related]
14. Sexual Functioning in Adolescents With Major Depressive Disorder: A Prospective Study.
Deumic Shultz E; Mills JA; Ellingrod VL; Bishop JR; Calarge CA
J Clin Psychiatry; 2021 Oct; 82(6):. PubMed ID: 34610228
[No Abstract] [Full Text] [Related]
15. Effects of SNS activation on SSRI-induced sexual side effects differ by SSRI.
Ahrold TK; Meston CM
J Sex Marital Ther; 2009; 35(4):311-9. PubMed ID: 19466669
[TBL] [Abstract][Full Text] [Related]
16. Burden of phase-specific sexual dysfunction with SSRIs.
Clayton A; Keller A; McGarvey EL
J Affect Disord; 2006 Mar; 91(1):27-32. PubMed ID: 16430968
[TBL] [Abstract][Full Text] [Related]
17. Serotonin 2A -1438 G/A and G-protein Beta3 subunit C825T polymorphisms in patients with depression and SSRI-associated sexual side-effects.
Bishop JR; Moline J; Ellingrod VL; Schultz SK; Clayton AH
Neuropsychopharmacology; 2006 Oct; 31(10):2281-8. PubMed ID: 16710319
[TBL] [Abstract][Full Text] [Related]
18. Sexual function assessment in postmenopausal women with the 14-item changes in sexual functioning questionnaire.
Llaneza P; Fernández-Iñarrea JM; Arnott B; García-Portilla MP; Chedraui P; Pérez-López FR
J Sex Med; 2011 Aug; 8(8):2144-51. PubMed ID: 21679299
[TBL] [Abstract][Full Text] [Related]
19. Comparison of interactive voice response (IVR) with paper administration of instruments to assess functional status, sexual function, and quality of life in elderly men.
Rosen RC; Stephens-Shields AJ; Cunningham GR; Cifelli D; Cella D; Farrar JT; Barrett-Connor E; Lewis CE; Pahor M; Hou X; Snyder PJ
Qual Life Res; 2016 Apr; 25(4):811-21. PubMed ID: 26358063
[TBL] [Abstract][Full Text] [Related]
20. Effect of buspirone on sexual dysfunction in depressed patients treated with selective serotonin reuptake inhibitors.
Landén M; Eriksson E; Agren H; Fahlén T
J Clin Psychopharmacol; 1999 Jun; 19(3):268-71. PubMed ID: 10350034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
